Literature DB >> 25343835

The central role of renal microcirculatory dysfunction in the pathogenesis of acute kidney injury.

Can Ince1.   

Abstract

Acute kidney injury (AKI) is a rapidly developing condition often associated with critical illness, with a high degree of morbidity and mortality, whose pathophysiology is ill understood. Recent investigations have identified the dysfunction of the renal microcirculation and its cellular and subcellular constituents as being central to the etiology of AKI. Injury is caused by inflammatory activation involving endothelial leucocyte interactions in combination with dysregulation of the homeostatis between oxygen, nitric oxide, and reactive oxygen species. Effective therapies expected to resolve AKI will have to control inflammation and restore this homeostasis. In order to apply and guide these therapies effectively, diagnostic tools aimed at physiological biomarkers of AKI for monitoring renal microcirculatory function in advance of changes in pharmacological biomarkers associated with structural damage of the kidney will need to be developed. 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25343835     DOI: 10.1159/000363203

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  13 in total

Review 1.  Bridging translation for acute kidney injury with better preclinical modeling of human disease.

Authors:  Nataliya I Skrypnyk; Leah J Siskind; Sarah Faubel; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

Review 2.  Endothelial cells: potential novel regulators of renal inflammation.

Authors:  Jim C Oates; Dayvia L Russell; Justin P Van Beusecum
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-07

3.  Protective role of antithrombin III in suppressing acute responses in a rat model of renal ischemia-reperfusion injury.

Authors:  Alena Firdus; Nesina Avdagić; Muhamed Fočak; Maja Mitrašinović-Brulić; Damir Suljević
Journal:  Mol Cell Biochem       Date:  2022-01-05       Impact factor: 3.396

4.  The Pathophysiology of Sepsis-Associated AKI.

Authors:  Shuhei Kuwabara; Eibhlin Goggins; Mark D Okusa
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-28       Impact factor: 10.614

Review 5.  Effects of impaired microvascular flow regulation on metabolism-perfusion matching and organ function.

Authors:  Tuhin K Roy; Timothy W Secomb
Journal:  Microcirculation       Date:  2020-12-21       Impact factor: 2.679

6.  Antithrombin III Protects Against Contrast-Induced Nephropathy.

Authors:  Zeyuan Lu; Dongsheng Cheng; Jianyong Yin; Rui Wu; Guangyuan Zhang; Qing Zhao; Niansong Wang; Feng Wang; Mingyu Liang
Journal:  EBioMedicine       Date:  2017-02-12       Impact factor: 8.143

7.  Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental cardiopulmonary bypass.

Authors:  Nicole A M Dekker; Anoek L I van Leeuwen; Matijs van Meurs; Jill Moser; Jeannette E Pankras; Nicole N van der Wel; Hans W Niessen; Marc G Vervloet; Alexander B A Vonk; Peter L Hordijk; Christa Boer; Charissa E van den Brom
Journal:  Intensive Care Med Exp       Date:  2021-06-25

Review 8.  Pathophysiology of COVID-19-associated acute kidney injury.

Authors:  Matthieu Legrand; Samira Bell; Lui Forni; Michael Joannidis; Jay L Koyner; Kathleen Liu; Vincenzo Cantaluppi
Journal:  Nat Rev Nephrol       Date:  2021-07-05       Impact factor: 42.439

Review 9.  The Complex Relationship of Extracorporeal Membrane Oxygenation and Acute Kidney Injury: Causation or Association?

Authors:  Daniel J Kilburn; Kiran Shekar; John F Fraser
Journal:  Biomed Res Int       Date:  2016-02-24       Impact factor: 3.411

Review 10.  Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives.

Authors:  Paraskevi Pavlakou; Vassilios Liakopoulos; Theodoros Eleftheriadis; Michael Mitsis; Evangelia Dounousi
Journal:  Oxid Med Cell Longev       Date:  2017-09-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.